SEC Filing Summary: Integrated Security Technologies, Inc.
Business Context and Reporting Period
This Form 8-K was filed by Integrated Security Technologies, Inc. (not Oramed Pharmaceuticals Inc.) on February 8, 2006, reporting events occurring on February 6, 2006. The registrant is incorporated in Nevada with principal executive offices in Vancouver, British Columbia, Canada.
Key Financial Metrics
The filing discloses a private placement transaction with the following specific metrics:
- Shares Issued: 22,981,228
- Price Per Share: $0.001
- Gross Proceeds: $22,981.23
- Payment Method: Promissory notes for the full amount, payable upon demand.
The filing text does not provide clear values for revenue, profit, cash flow, margins, existing debt, or overall liquidity outside of this specific transaction.
Material Changes
The primary material change is the unregistered sale of equity securities under Item 3.02. The company issued shares to 7 non-U.S. persons in an offshore transaction relying on Regulation S and/or Section 4(2) of the Securities Act of 1933.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or specific risk factors beyond the standard disclosure of the unregistered sale. The transaction structure involves promissory notes rather than immediate cash, which may impact immediate liquidity.
Investor Verification Checklist
- Verify the discrepancy between the metadata company name (Oramed Pharmaceuticals Inc.) and the filing registrant (Integrated Security Technologies, Inc.).
- Confirm the status of the promissory notes issued for the shares and the likelihood of collection.
- Review the company's current cash position to assess the impact of receiving notes rather than cash.
- Check for subsequent filings regarding the conversion or repayment of the promissory notes.